Gedeon Richter

Gedeon Richter

Community score

+1.05 -55
Industry: Biotechnology & Pharmaceuticals
Listing country: Hungary
Year added: 2022

Incorporated in 1901, a prominent enterprise with headquarters in Budapest, Hungary specializes in several critical business categories including pharmaceutical manufacturing, sales and marketing, research and development, biotechnology, generic drugs, gynecological therapies, and central nervous system therapies. The company's significant brands include Richter, which is widely recognized as a corporate brand encompassing a diverse product range. Additionally, Esmya and Cariprazine are among the key branded products in the company's portfolio, with Cariprazine being marketed as Reagila in Europe and Vraylar in the United States for the treatment of mental health disorders. This enterprise ensures a strong global presence, with its products and services being distributed in vital markets such as Russia, the United States, numerous European countries (with Germany, Poland, and Hungary being noteworthy examples), the Commonwealth of Independent States (CIS) countries, and China. It is important to acknowledge that the relevance of business segments, brands, and essential markets is subject to change, potentially leading to the rise of new pivotal regions or products in the future. (Powered by AI)

Show Company Information
You view a limited profile page without scores and metrics availability. Subscribing users get to see more advanced data, want to see it in action? Click on a company you are interested in: .
My impact scoreBeta
List View